Vanguard Investments Australia
WGS icon

Vanguard Investments Australia’s GeneDx Holdings WGS Stock Holding History

Vanguard Investments Australia’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Hold
4,943
– – ﹤0.01% 1846
2026
Q1 		$317K Buy
+4,943
New +$451K ﹤0.01% 1812

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Investments Australia's WGS Position: Q2 2026 in Review

Vanguard Investments Australia held its GeneDx Holdings (WGS) position steady in Q2 2026 at 4,943 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

Vanguard Investments Australia first reported a position in WGS in Q1 2026 and has held it in 2 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Vanguard Investments Australia held 4,943 shares of GeneDx Holdings worth $339K as of Q2 2026.
  • Vanguard Investments Australia left its GeneDx Holdings share count unchanged in Q2 2026.
  • GeneDx Holdings made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1846 holding.
  • Vanguard Investments Australia first reported a position in GeneDx Holdings in Q1 2026 and has held it in 2 quarters since.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.